2020 OCT 15 Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

Of those that took HCQ before getting to hospital the death rate was reduced to 10.5%. Those that didn’t get HCQ before they got to hospital 29.5% died. To those who have lobbied against HCQ because you want to profit from other treatments – hell awaits you, you’ve committed crimes against humanity. To those useful idiots of the left, that have aided and abetted these crimes because of your TDS, you have blood on your hands.

  Continue Reading